Ceftriaxone
Avoid to usage in case of Hypersensitivity
It binds to penicillin-binding proteins (PBPs) in the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This weakens the cell wall, leading to osmotic lysis and cell death
Information will be updated soon.
Information will be updated soon.
Information will be updated soon.
Half-life 6-9 hr, 58%-96% eliminated unchanged in urine, crosses placenta, excreted in breast milk
Route of Administration
Intravenous (IV) intramuscular (IM)
General Dose
- Adult/child >12 yr: IM/IV 1-2 g/day, max 4 g/24 hr
- Child ≤12 yr: IM/IV 50-75 mg/kg/day in equal doses q12-24hr
Indicated Dose
Pneumonia, Hospital-acquired pneumonia Intra-abdominal infections, Complicated urinary-tract infections (UTI), Acute exacerbations of chronic obstructive pulmonary disease.
IV injection or IV infusion, Adult: 1–2g once daily, 2g dose to be used for hospital-acquired pneumonia and severe cases
Cellulitis, Erysipelas Moderate diabetic foot infection mild or leg ulceration or Severe, diabetic.
IV injection or IV infusion Adult: 2g once daily
Prophylaxis of infection from human bites in combination with other drugs, Prophylaxis of infection from animal bites in combination with other drugs, Treatment of infection from human bites in combination with other drugs
IV injection or IV infusion Adult: 2goncedaily
Complicated skin and soft tissue infections, infection of bones and joints
IV injection or IV infusion Adult: 2g once daily
Suspected bacterial infection in neutropenic patients
IV injection or IV infusion Adult: 2–4g daily, dose at higher end of the recommended rang used in severe cases
Bacterial meningitis Bacterial endocarditis
IV injection or IV infusion Adult: 2–4g daily, doses at the higher end of the recommended range used in severe cases
Child1month–11years (body-weight up to50 kg): 80–100mg/kg once daily,100mg/kg once daily dose should be used for bacterial endo carditis; maximum 4g per day
Child 9–11years(body-weight 50kg and above): 2–4g once daily, doses at the higher end of the Child12–17years: 2–4g once daily, doses at the higher end of the recommended range used in severe cases
IV injection Child 9–11years (body-weight50kg and above): 2–4g once daily, doses at the higher end of the recommended range used in severe cases ;doses of 50mg/kg or more should be given by infusion
Child12–17years: 2–4g once daily, doses at the higher end of the recommended range used in severe cases
IM injection Child1month to 11years (body-weight up to 50kg): 80–100mg/kg daily,100mg/kg daily dose should be used for bacterial endocarditis; maximum 4g / day
Child 9–11years (body-weight 50kg and above): 2–4g daily, doses at the higher end of the recommended range used in severe cases
Child12–17years: 2–4g daily, doses at the higher end of the recommended range used in severe cases
Surgical prophylaxis
IV injection or IV infusion Adult: 2g for1dose, dose to be administered 30–90 minutes before procedure
Pelvic inflammatory disease
Deep IM injection Adult: 500mg 1dose
Gonococcal conjunctivitis Uncomplicated gonorrhea anogenital and pharyngeal infection, when sensitivity unknown
By Deep IM Injection Adult: 1g for 1dose
Gonococcal epididymo-orchitis
By Deep IM Injection Adult: 1g for 1dose, to be followed by an additional anti-bacterial course to treat epididymo-orchitis
Syphilis
Deep IM injection Adult: 0.5–1g once daily for 10–14 days, increased to 2g once daily for neuro Syphilis
Lyme disease affecting CNS.
IV injection or IV infusion Adult: 2g twice daily for 21days, alternatively 4g once daily for 21days
Lyme arthritis Acrodermatitis chronic atrophicans
IV injection or IV infusion Adult: 2g once daily for 28 days
Lymecarditis
IV injection or IV infusion Adult: 2g once daily for 21days
Prevention of secondary case of meningococcal meningitis
By IM injection Adult: 250mg for1dose.
Prevention of secondary case of Haemophiles influenzae type B disease
By IM injection, or by IV Injection, or by IV infusion ▶ Adult: 1g daily for 2 days.
Acute otitis media
By Deep IM Injection Adult: 1–2g for1dose, dose can be given for 3 days if severely ill or previous therapy failed
Acute prostatitis
By Slow IV Injection, or By IV infusion Adult: 2g once daily
Pain or irritation at the injection site, diarrhea, nausea, and headache. Serious risks include severe allergic reactions (anaphylaxis), C. diff-associated diarrhea, and gallbladder or kidney issues. Seek immediate medical care if you experience severe abdominal pain, chest pain, or blistering skin
Many products should not be used with calcium salts (mixed or administered) or
H2 blocker antacids (PO) Increase: bleeding—anticoagulants, thrombolytics, NSAIDs (ceftriaxone) Increase: toxicity—aminoglycosides, furosemide
loop diuretics, probenecid
Decrease: absorption of cefdinir—iron
Drug/Food
Decrease: absorption—iron-rich cereal, infant formula
Drug/Lab Test
Increase: ALT, AST, alkaline phosphatase, LDH, bilirubin, BUN, creatinine False increase: creatinine (serum urine), urinary 17-KS False positive: urinary protein, direct
Coombs’ test, urine glucose Interference: cross-matching
Information will be updated soon.
Assess:
Infection: characteristics of wounds, sputum, urine, stool, WBC >10,000/ mm3, fever; obtain baseline and periodically during treatment • Cross-sensitivity to penicillin, other cephalosporins; hypersensitivity reaction may occur
• Obtain C&S prior to treatment, may start treatment before results are received
• Blood studies: AST, ALT, CBC, Hct, bilirubin,
LDH, alkaline phosphatase, Coombs’ test monthly if patient is on long-term therapy
• Electrolytes: potassium, sodium, chloride monthly if patient is on long-term therapy
